{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:47:47Z","timestamp":1793119667068,"version":"4.5.0"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente 2025"],"award-info":[{"award-number":["Ricerca Corrente 2025"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02693-8","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T08:35:54Z","timestamp":1779698154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A sweet danger: the silent link between hyperinsulinemia and gastric cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Pasqualina","family":"Laurenziello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Luongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lospinoso Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabino","family":"Russi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geppino","family":"Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Laurino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2693_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1146\/annurev-physiol-020518-114640","volume":"81","author":"G Liu","year":"2019","unstructured":"Liu G, Summer R. Cellular metabolism in lung health and disease. Annu Rev Physiol. 2019;81:403\u201328. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114640.","journal-title":"Annu Rev Physiol"},{"key":"2693_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20:74\u201388. https:\/\/doi.org\/10.1038\/s41568-019-0216-7.","journal-title":"Nat Rev Cancer"},{"key":"2693_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang C-H, Li N. Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer. 2024;23:203. https:\/\/doi.org\/10.1186\/s12943-024-02119-3.","journal-title":"Mol Cancer"},{"key":"2693_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1158\/jcr.1925.148","volume":"9","author":"O Warburg","year":"1925","unstructured":"Warburg O. The metabolism of carcinoma cells. J Cancer Res. 1925;9:148\u201363. https:\/\/doi.org\/10.1158\/jcr.1925.148. American Association for Cancer Research.","journal-title":"J Cancer Res"},{"key":"2693_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21:669\u201380. https:\/\/doi.org\/10.1038\/s41568-021-00378-6.","journal-title":"Nat Rev Cancer"},{"key":"2693_CR6","doi-asserted-by":"publisher","first-page":"151225","DOI":"10.1016\/j.ejcb.2022.151225","volume":"101","author":"J Di Gregorio","year":"2022","unstructured":"Di Gregorio J, Petricca S, Iorio R, Toniato E, Flati V. Mitochondrial and metabolic alterations in cancer cells. Eur J Cell Biol. 2022;101:151225. https:\/\/doi.org\/10.1016\/j.ejcb.2022.151225.","journal-title":"Eur J Cell Biol"},{"issue":"5","key":"2693_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/cancers12051119","volume":"12","author":"S Cassim","year":"2020","unstructured":"Cassim S, Vu\u010deti\u0107 M, \u017ddralevi\u0107 M, Pouyssegur J. Warburg and beyond: The power of mitochondrial metabolism to collaborate or replace fermentative glycolysis in cancer. Cancers Basel. 2020;12(5):1119. https:\/\/doi.org\/10.3390\/cancers12051119. Cited 2026 Jan 27.","journal-title":"Cancers Basel"},{"key":"2693_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-024-00482-x","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang J, Shay C, Saba NF, Teng Y. Cancer metabolism and carcinogenesis. Exp Hematol Oncol. 2024;13:10. https:\/\/doi.org\/10.1186\/s40164-024-00482-x.","journal-title":"Exp Hematol Oncol"},{"key":"2693_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-65768-0_1","volume":"1311","author":"S Bose","year":"2021","unstructured":"Bose S, Zhang C, Le A. Glucose metabolism in cancer: the Warburg effect and beyond. Adv Exp Med Biol. 2021;1311:3\u201315. https:\/\/doi.org\/10.1007\/978-3-030-65768-0_1.","journal-title":"Adv Exp Med Biol"},{"key":"2693_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/nu15040921","volume":"15","author":"AI Aedh","year":"2023","unstructured":"Aedh AI, Alshahrani MS, Huneif MA, Pryme IF, Oruch R. A glimpse into milestones of insulin resistance and an updated review of its management. Nutrients. 2023;15:921. https:\/\/doi.org\/10.3390\/nu15040921.","journal-title":"Nutrients"},{"key":"2693_CR11","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.3390\/ijms25105488","volume":"25","author":"JAMJL Janssen","year":"2024","unstructured":"Janssen JAMJL. Overnutrition, hyperinsulinemia and ectopic fat: It is time for a paradigm shift in the management of type 2 diabetes. Int J Mol Sci. 2024;25:5488. https:\/\/doi.org\/10.3390\/ijms25105488.","journal-title":"Int J Mol Sci"},{"key":"2693_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s13679-017-0261-z","volume":"6","author":"KA Erion","year":"2017","unstructured":"Erion KA, Corkey BE. Hyperinsulinemia: a cause of obesity? Curr Obes Rep. 2017;6:178\u201386. https:\/\/doi.org\/10.1007\/s13679-017-0261-z.","journal-title":"Curr Obes Rep"},{"key":"2693_CR13","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.3390\/ijms222011137","volume":"22","author":"E Chiefari","year":"2021","unstructured":"Chiefari E, Mirabelli M, La Vignera S, Tanyola\u00e7 S, Foti DP, Aversa A, et al. Insulin resistance and cancer: in search for a causal link. Int J Mol Sci. 2021;22:11137. https:\/\/doi.org\/10.3390\/ijms222011137.","journal-title":"Int J Mol Sci"},{"key":"2693_CR14","doi-asserted-by":"publisher","first-page":"111315","DOI":"10.1016\/j.biopha.2021.111315","volume":"137","author":"B Ahmed","year":"2021","unstructured":"Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:111315. https:\/\/doi.org\/10.1016\/j.biopha.2021.111315.","journal-title":"Biomed Pharmacother"},{"key":"2693_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1172\/JCI113339","volume":"81","author":"KS Polonsky","year":"1988","unstructured":"Polonsky KS, Given BD, Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988;81:442\u20138.","journal-title":"J Clin Invest"},{"key":"2693_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4093\/dmj.2020.0250","volume":"45","author":"AMY Zhang","year":"2021","unstructured":"Zhang AMY, Wellberg EA, Kopp JL, Johnson JD. Hyperinsulinemia in obesity, inflammation, and cancer. Diabetes Metab J. 2021;45:285\u2013311. https:\/\/doi.org\/10.4093\/dmj.2020.0250.","journal-title":"Diabetes Metab J"},{"key":"2693_CR17","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s10620-012-2198-0","volume":"57","author":"C-J Tsai","year":"2012","unstructured":"Tsai C-J, Giovannucci EL. Hyperinsulinemia, insulin resistance, vitamin D, and colorectal cancer among whites and African Americans. Dig Dis Sci. 2012;57:2497\u2013503. https:\/\/doi.org\/10.1007\/s10620-012-2198-0.","journal-title":"Dig Dis Sci"},{"key":"2693_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.domaniend.2015.07.001","volume":"54","author":"LH Baumgard","year":"2016","unstructured":"Baumgard LH, Hausman GJ, Sanz Fernandez MV. Insulin: pancreatic secretion and adipocyte regulation. Domest Anim Endocrinol. 2016;54:76\u201384. https:\/\/doi.org\/10.1016\/j.domaniend.2015.07.001.","journal-title":"Domest Anim Endocrinol"},{"key":"2693_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fendo.2011.00076","volume":"2","author":"CW Ward","year":"2011","unstructured":"Ward CW, Lawrence MC. Landmarks in insulin research. Front Endocrinol (Lausanne). 2011;2:76. https:\/\/doi.org\/10.3389\/fendo.2011.00076.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2693_CR20","doi-asserted-by":"publisher","first-page":"15006","DOI":"10.3390\/ijms241915006","volume":"24","author":"MA Galal","year":"2023","unstructured":"Galal MA, Alouch SS, Alsultan BS, Dahman H, Alyabis NA, Alammar SA, et al. Insulin receptor isoforms and insulin growth factor-like receptors: implications in cell signaling, carcinogenesis, and chemoresistance. Int J Mol Sci. 2023;24:15006. https:\/\/doi.org\/10.3390\/ijms241915006.","journal-title":"Int J Mol Sci"},{"key":"2693_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1073\/pnas.86.1.114","volume":"86","author":"S Seino","year":"1989","unstructured":"Seino S, Seino M, Nishi S, Bell GI. Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci U S A. 1989;86:114\u20138. https:\/\/doi.org\/10.1073\/pnas.86.1.114.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2693_CR22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/er.2008-0047","volume":"30","author":"A Belfiore","year":"2009","unstructured":"Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009;30:586\u2013623. https:\/\/doi.org\/10.1210\/er.2008-0047.","journal-title":"Endocr Rev"},{"key":"2693_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1042\/BJ20061709","volume":"403","author":"S Benyoucef","year":"2007","unstructured":"Benyoucef S, Surinya KH, Hadaschik D, Siddle K. Characterization of insulin\/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. Biochem J. 2007;403:603\u201313. https:\/\/doi.org\/10.1042\/BJ20061709.","journal-title":"Biochem J"},{"key":"2693_CR24","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1021\/acs.biochem.5b00805","volume":"54","author":"SA Tatulian","year":"2015","unstructured":"Tatulian SA. Structural dynamics of insulin receptor and transmembrane signaling. Biochemistry. 2015;54:5523\u201332. https:\/\/doi.org\/10.1021\/acs.biochem.5b00805.","journal-title":"Biochemistry"},{"key":"2693_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1042\/BCJ20210134","volume":"479","author":"BP Leitner","year":"2022","unstructured":"Leitner BP, Siebel S, Akingbesote ND, Zhang X, Perry RJ. Insulin and cancer: a tangled web. Biochem J. 2022;479:583\u2013607. https:\/\/doi.org\/10.1042\/BCJ20210134.","journal-title":"Biochem J"},{"key":"2693_CR26","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.4161\/cc.10.11.15824","volume":"10","author":"LM Shaw","year":"2011","unstructured":"Shaw LM. The insulin receptor substrate (IRS) proteins. Cell Cycle. 2011;10:1750\u20136. https:\/\/doi.org\/10.4161\/cc.10.11.15824.","journal-title":"Cell Cycle"},{"key":"2693_CR27","doi-asserted-by":"publisher","first-page":"e70295","DOI":"10.1002\/mco2.70295","volume":"6","author":"M Jiang","year":"2025","unstructured":"Jiang M, Zhang K, Zhang Z, Zeng X, Huang Z, Qin P, et al. PI3K\/AKT\/mTOR axis in cancer: from pathogenesis to treatment. MedComm. 2025;6:e70295. https:\/\/doi.org\/10.1002\/mco2.70295.","journal-title":"MedComm"},{"key":"2693_CR28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ctrv.2013.03.009","volume":"39","author":"KS Saini","year":"2013","unstructured":"Saini KS, Loi S, de Azambuja E, Metzger-Filho O, Saini ML, Ignatiadis M, et al. Targeting the PI3K\/AKT\/mTOR and Raf\/MEK\/ERK pathways in the treatment of breast cancer. Cancer Treat Rev. 2013;39:935\u201346. https:\/\/doi.org\/10.1016\/j.ctrv.2013.03.009.","journal-title":"Cancer Treat Rev"},{"key":"2693_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394. https:\/\/doi.org\/10.1016\/j.semcancer.2021.06.019.","journal-title":"Semin Cancer Biol"},{"key":"2693_CR30","doi-asserted-by":"publisher","first-page":"re15","DOI":"10.1126\/stke.2122003re15","volume":"2003","author":"TE Harris","year":"2003","unstructured":"Harris TE, Lawrence JC. TOR signaling. Sci STKE. 2003;2003:re15. https:\/\/doi.org\/10.1126\/stke.2122003re15.","journal-title":"Sci STKE"},{"key":"2693_CR31","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1021\/pr8001645","volume":"7","author":"J Wang","year":"2008","unstructured":"Wang J, Yuan Y, Zhou Y, Guo L, Zhang L, Kuai X, et al. Protein interaction data set highlighted with human Ras-MAPK\/PI3K signaling pathways. J Proteome Res American Chemical Society. 2008;7:3879\u201389. https:\/\/doi.org\/10.1021\/pr8001645.","journal-title":"J Proteome Res American Chemical Society"},{"key":"2693_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"2693_CR33","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","volume":"26","author":"X Wan","year":"2007","unstructured":"Wan X, Harkavy B, Shen N, Grohar P, Helman LJ. Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene. 2007;26:1932\u201340. https:\/\/doi.org\/10.1038\/sj.onc.1209990. Nature Publishing Group;","journal-title":"Oncogene"},{"key":"2693_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43556-022-00110-2","volume":"3","author":"Q Li","year":"2022","unstructured":"Li Q, Li Z, Luo T, Shi H. Targeting the PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways for cancer therapy. Mol Biomed. 2022;3:47. https:\/\/doi.org\/10.1186\/s43556-022-00110-2.","journal-title":"Mol Biomed"},{"key":"2693_CR35","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.3390\/diagnostics14192132","volume":"14","author":"A Asiri","year":"2024","unstructured":"Asiri A, Al Qarni A, Bakillah A. The interlinking metabolic association between type 2 diabetes mellitus and cancer: Molecular mechanisms and therapeutic insights. Diagnostics (Basel). 2024;14:2132. https:\/\/doi.org\/10.3390\/diagnostics14192132. Basel, Switzerland.","journal-title":"Diagnostics (Basel)"},{"key":"2693_CR36","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/biomedicines9080870","volume":"9","author":"S Chaithongyot","year":"2021","unstructured":"Chaithongyot S, Jantaree P, Sokolova O, Naumann M. NF-\u03baB in gastric cancer development and therapy. Biomedicines. 2021;9:870. https:\/\/doi.org\/10.3390\/biomedicines9080870.","journal-title":"Biomedicines"},{"key":"2693_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/35096075","volume":"2","author":"P Cohen","year":"2001","unstructured":"Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001;2:769\u201376. https:\/\/doi.org\/10.1038\/35096075.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2693_CR38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-\u03baB signaling pathways. Nat Immunol. 2011;12:695\u2013708. https:\/\/doi.org\/10.1038\/ni.2065.","journal-title":"Nat Immunol"},{"key":"2693_CR39","doi-asserted-by":"publisher","first-page":"1396022","DOI":"10.3389\/fendo.2024.1396022","volume":"15","author":"Y-Y Zhang","year":"2024","unstructured":"Zhang Y-Y, Li Y-J, Xue C-D, Li S, Gao Z-N, Qin K-R. Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms. Front Endocrinol (Lausanne). 2024;15:1396022. https:\/\/doi.org\/10.3389\/fendo.2024.1396022.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2693_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/s0092-8674(04)00452-0","volume":"117","author":"D Accili","year":"2004","unstructured":"Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004;117:421\u20136. https:\/\/doi.org\/10.1016\/s0092-8674(04)00452-0.","journal-title":"Cell"},{"issue":"4","key":"2693_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/toxins9040119","volume":"9","author":"O Sokolova","year":"2017","unstructured":"Sokolova O, Naumann M. NF\u2010\u03baB signaling in gastric cancer. Toxins Basel. 2017;9(4):119. https:\/\/doi.org\/10.3390\/toxins9040119. Cited 2026 Mar 26.","journal-title":"Toxins Basel"},{"key":"2693_CR42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","volume":"8","author":"T Porstmann","year":"2008","unstructured":"Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 2008;8:224\u201336. https:\/\/doi.org\/10.1016\/j.cmet.2008.07.007.","journal-title":"Cell Metab"},{"key":"2693_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","volume":"17","author":"B Faubert","year":"2013","unstructured":"Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z, et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 2013;17:113\u201324. https:\/\/doi.org\/10.1016\/j.cmet.2012.12.001.","journal-title":"Cell Metab"},{"key":"2693_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/BJ20131344","volume":"459","author":"SA Hawley","year":"2014","unstructured":"Hawley SA, Ross FA, Gowans GJ, Tibarewal P, Leslie NR, Hardie DG. Phosphorylation by Akt within the ST loop of AMPK-\u03b11 down-regulates its activation in tumour cells. Biochem J. 2014;459:275\u201387. https:\/\/doi.org\/10.1042\/BJ20131344.","journal-title":"Biochem J"},{"key":"2693_CR45","doi-asserted-by":"publisher","first-page":"e23878","DOI":"10.4161\/jkst.23878","volume":"2","author":"CM Wunderlich","year":"2013","unstructured":"Wunderlich CM, H\u00f6velmeyer N, Wunderlich FT. Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAKSTAT. 2013;2:e23878. https:\/\/doi.org\/10.4161\/jkst.23878.","journal-title":"JAKSTAT"},{"key":"2693_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrendo.2010.171","volume":"7","author":"PE Clayton","year":"2011","unstructured":"Clayton PE, Banerjee I, Murray PG, Renehan AG. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol Nature Publishing Group. 2011;7:11\u201324. https:\/\/doi.org\/10.1038\/nrendo.2010.171.","journal-title":"Nat Rev Endocrinol Nature Publishing Group"},{"key":"2693_CR47","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1210\/jc.2010-1895","volume":"96","author":"AS Cornford","year":"2011","unstructured":"Cornford AS, Barkan AL, Horowitz JF. Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. J Clin Endocrinol Metab. 2011;96:824\u201330. https:\/\/doi.org\/10.1210\/jc.2010-1895.","journal-title":"J Clin Endocrinol Metab"},{"key":"2693_CR48","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.3390\/ijms22157797","volume":"22","author":"JAMJL Janssen","year":"2021","unstructured":"Janssen JAMJL. Hyperinsulinemia and its pivotal role in aging, obesity, type 2 diabetes, cardiovascular disease and cancer. Int J Mol Sci. 2021;22:7797. https:\/\/doi.org\/10.3390\/ijms22157797.","journal-title":"Int J Mol Sci"},{"key":"2693_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0026-0495(95)90219-8","volume":"44","author":"J Frystyk","year":"1995","unstructured":"Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. Free insulin-like growth factors in human obesity. Metabolism. 1995;44:37\u201344. https:\/\/doi.org\/10.1016\/0026-0495(95)90219-8.","journal-title":"Metabolism"},{"key":"2693_CR50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2337\/db09-0583","volume":"59","author":"MP Brugts","year":"2010","unstructured":"Brugts MP, van Duijn CM, Hofland LJ, Witteman JC, Lamberts SWJ, Janssen JAMJL. Igf-I bioactivity in an elderly population: relation to insulin sensitivity, insulin levels, and the metabolic syndrome. Diabetes. 2010;59:505\u20138. https:\/\/doi.org\/10.2337\/db09-0583.","journal-title":"Diabetes"},{"key":"2693_CR51","doi-asserted-by":"publisher","first-page":"111038","DOI":"10.1016\/j.mce.2020.111038","volume":"518","author":"R Sharma","year":"2020","unstructured":"Sharma R, Kopchick JJ, Puri V, Sharma VM. Effect of growth hormone on insulin signaling. Mol Cell Endocrinol. 2020;518:111038. https:\/\/doi.org\/10.1016\/j.mce.2020.111038.","journal-title":"Mol Cell Endocrinol"},{"key":"2693_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3803\/EnM.2024.101","volume":"39","author":"EC Nijenhuis-Noort","year":"2024","unstructured":"Nijenhuis-Noort EC, Berk KA, Neggers SJCMM, van der Lely AJ. The fascinating interplay between growth hormone, insulin-like growth factor-1, and insulin. Endocrinol Metab Seoul. 2024;39:83\u20139. https:\/\/doi.org\/10.3803\/EnM.2024.101.","journal-title":"Endocrinol Metab Seoul"},{"key":"2693_CR53","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1210\/jcem.85.12.7017","volume":"85","author":"KC Leung","year":"2000","unstructured":"Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab. 2000;85:4712\u201320. https:\/\/doi.org\/10.1210\/jcem.85.12.7017.","journal-title":"J Clin Endocrinol Metab"},{"key":"2693_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2017.02.014","volume":"393","author":"L Xu","year":"2017","unstructured":"Xu L, Zhou R, Yuan L, Wang S, Li X, Ma H, et al. IGF1\/IGF1R\/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis. Cancer Lett. 2017;393:76\u201385. https:\/\/doi.org\/10.1016\/j.canlet.2017.02.014.","journal-title":"Cancer Lett"},{"key":"2693_CR55","doi-asserted-by":"publisher","first-page":"170892","DOI":"10.1016\/j.peptides.2022.170892","volume":"158","author":"F Ghafari","year":"2022","unstructured":"Ghafari F, Alizadeh AM, Agah S, Irani S, Mokhtare M. Insulin-like growth factor 1 serum levels in different stages of gastric cancer and their association with Helicobacter pylori status. Peptides. 2022;158:170892. https:\/\/doi.org\/10.1016\/j.peptides.2022.170892.","journal-title":"Peptides"},{"key":"2693_CR56","doi-asserted-by":"publisher","first-page":"7000","DOI":"10.3892\/ol.2018.8234","volume":"15","author":"C Su","year":"2018","unstructured":"Su C, Wang W, Wang C. IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1\/STAT3 signaling pathway. Oncol Lett. 2018;15:7000\u20136. https:\/\/doi.org\/10.3892\/ol.2018.8234.","journal-title":"Oncol Lett"},{"key":"2693_CR57","doi-asserted-by":"publisher","first-page":"1016381","DOI":"10.3389\/fmed.2023.1016381","volume":"10","author":"KNC Duong","year":"2023","unstructured":"Duong KNC, Tan CJ, Rattanasiri S, Thakkinstian A, Anothaisintawee T, Chaiyakunapruk N. Comparison of diagnostic accuracy for diabetes diagnosis: a systematic review and network meta-analysis. Front Med (Lausanne). 2023;10:1016381. https:\/\/doi.org\/10.3389\/fmed.2023.1016381.","journal-title":"Front Med (Lausanne)"},{"key":"2693_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4158\/EP09031.OR","volume":"16","author":"JL Johnson","year":"2010","unstructured":"Johnson JL, Duick DS, Chui MA, Aldasouqi SA. Identifying prediabetes using fasting insulin levels. Endocr Pract. 2010;16:47\u201352. https:\/\/doi.org\/10.4158\/EP09031.OR.","journal-title":"Endocr Pract"},{"key":"2693_CR59","doi-asserted-by":"publisher","first-page":"e230483","DOI":"10.20945\/2359-4292-2023-0483","volume":"68","author":"Y Schrank","year":"2024","unstructured":"Schrank Y, Fontes R, Perozo AFDF, Ara\u00fajo PB, Pinheiro MFMC, Gomes DMV, et al. Proposal for fasting insulin and HOMA-IR reference intervals based on an extensive Brazilian laboratory database. Arch Endocrinol Metab. 2024;68:e230483. https:\/\/doi.org\/10.20945\/2359-4292-2023-0483.","journal-title":"Arch Endocrinol Metab"},{"key":"2693_CR60","doi-asserted-by":"publisher","first-page":"030006052412855","DOI":"10.1177\/03000605241285550","volume":"52","author":"CE Kosmas","year":"2024","unstructured":"Kosmas CE, Sourlas A, Oikonomakis K, Zoumi E-A, Papadimitriou A, Kostara CE. Biomarkers of insulin sensitivity\/resistance. J Int Med Res. 2024;52:03000605241285550. https:\/\/doi.org\/10.1177\/03000605241285550.","journal-title":"J Int Med Res"},{"key":"2693_CR61","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.3390\/jcm13102865","volume":"13","author":"A \u0141upi\u0144ska","year":"2024","unstructured":"\u0141upi\u0144ska A, Aszkie\u0142owicz S, Kowalik D, Jeziorny K, Kolasa-Kici\u0144ska M, Smalczewska P, et al. Comparison of the clinical utility of two insulin resistance indices: IRI-HOMA and IRI-Belfiore in diagnosing insulin resistance and metabolic complications in children based on the results obtained for the Polish population. J Clin Med. 2024;13:2865. https:\/\/doi.org\/10.3390\/jcm13102865.","journal-title":"J Clin Med"},{"key":"2693_CR62","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1172\/JCI112886","volume":"79","author":"RN Bergman","year":"1987","unstructured":"Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest. 1987;79:790\u2013800. https:\/\/doi.org\/10.1172\/JCI112886.","journal-title":"J Clin Invest"},{"key":"2693_CR63","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4093\/dmj.2021.0220","volume":"45","author":"SY Park","year":"2021","unstructured":"Park SY, Gautier J-F, Chon S. Assessment of insulin secretion and insulin resistance in human. Diabetes Metab J. 2021;45:641\u201354. https:\/\/doi.org\/10.4093\/dmj.2021.0220.","journal-title":"Diabetes Metab J"},{"key":"2693_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00125-009-1547-9","volume":"53","author":"A Tura","year":"2010","unstructured":"Tura A, Sbrignadello S, Succurro E, Groop L, Sesti G, Pacini G. An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics. Diabetologia. 2010;53:144\u201352. https:\/\/doi.org\/10.1007\/s00125-009-1547-9.","journal-title":"Diabetologia"},{"key":"2693_CR65","doi-asserted-by":"publisher","first-page":"1594548","DOI":"10.3389\/fendo.2025.1594548","volume":"16","author":"T Sun","year":"2025","unstructured":"Sun T, Liu J. Study on the correlation between triglyceride glucose index, triglyceride glucose index to high-density lipoprotein cholesterol ratio, and the risk of diabetes in nonalcoholic fatty liver disease. Front Endocrinol. 2025;16:1594548. https:\/\/doi.org\/10.3389\/fendo.2025.1594548. Cited 2026 Jan 19.","journal-title":"Front Endocrinol"},{"key":"2693_CR66","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/biomedicines12071493","volume":"12","author":"P Baneu","year":"2024","unstructured":"Baneu P, V\u0103c\u0103rescu C, Dr\u0103gan S-R, Cirin L, Laz\u0103r-H\u00f6cher A-I, Cozgarea A, et al. The triglyceride\/HDL ratio as a surrogate biomarker for insulin resistance. Biomedicines. 2024;12:1493. https:\/\/doi.org\/10.3390\/biomedicines12071493.","journal-title":"Biomedicines"},{"key":"2693_CR67","doi-asserted-by":"publisher","first-page":"e0326179","DOI":"10.1371\/journal.pone.0326179","volume":"20","author":"M Cabanillas-Lazo","year":"2025","unstructured":"Cabanillas-Lazo M, Quispe-Vicu\u00f1a C, Pascual-Guevara M, Cruzalegui-Baz\u00e1n C, Duran-Pecho A, Paz-Ibarra J, et al. Diagnostic accuracy of triglyceride to glucose index and triglyceride\/high-density lipoprotein index for insulin resistance among children and adolescents: A systematic review. PLoS ONE. 2025;20:e0326179. https:\/\/doi.org\/10.1371\/journal.pone.0326179.","journal-title":"PLoS ONE"},{"key":"2693_CR68","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3390\/diagnostics15070861","volume":"15","author":"A Aznar-Esquivel","year":"2025","unstructured":"Aznar-Esquivel A, G\u00f3mez-Bernal F, Garc\u00eda-Gonz\u00e1lez M, Hern\u00e1ndez-Diaz M, Heras-Recuero E, de Vera-Gonz\u00e1lez A, et al. The metabolic score for insulin resistance (METS-IR), a predictor of cardiovascular events, relates to disease activity in patients with rheumatoid arthritis. Diagnostics (Basel). 2025;15:861. https:\/\/doi.org\/10.3390\/diagnostics15070861.","journal-title":"Diagnostics (Basel)"},{"key":"2693_CR69","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41440-023-01566-7","volume":"47","author":"N Sasaki","year":"2024","unstructured":"Sasaki N, Ueno Y, Higashi Y. Indicators of insulin resistance in clinical practice. Hypertens Res. 2024;47:978\u201380. https:\/\/doi.org\/10.1038\/s41440-023-01566-7.","journal-title":"Hypertens Res"},{"key":"2693_CR70","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","volume":"294","author":"R Muniyappa","year":"2008","unstructured":"Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15-26. https:\/\/doi.org\/10.1152\/ajpendo.00645.2007.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"2693_CR71","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","volume":"85","author":"A Katz","year":"2000","unstructured":"Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402\u201310. https:\/\/doi.org\/10.1210\/jcem.85.7.6661.","journal-title":"J Clin Endocrinol Metab"},{"key":"2693_CR72","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","volume":"8","author":"E Leighton","year":"2017","unstructured":"Leighton E, Sainsbury CA, Jones GC. A practical review of C-Peptide testing in diabetes. Diabetes Ther. 2017;8:475\u201387. https:\/\/doi.org\/10.1007\/s13300-017-0265-4.","journal-title":"Diabetes Ther"},{"key":"2693_CR73","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1172\/JCI29126","volume":"116","author":"T Kadowaki","year":"2006","unstructured":"Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784\u201392. https:\/\/doi.org\/10.1172\/JCI29126.","journal-title":"J Clin Invest"},{"key":"2693_CR74","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cen.12086","volume":"78","author":"IR Wallace","year":"2013","unstructured":"Wallace IR, McKinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance. Clin Endocrinol (Oxf). 2013;78:321\u20139. https:\/\/doi.org\/10.1111\/cen.12086.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2693_CR75","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1093\/humrep\/del175","volume":"21","author":"M-J Chen","year":"2006","unstructured":"Chen M-J, Yang W-S, Yang J-H, Hsiao CK, Yang Y-S, Ho H-N. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Hum Reprod. 2006;21:2266\u201371. https:\/\/doi.org\/10.1093\/humrep\/del175.","journal-title":"Hum Reprod"},{"key":"2693_CR76","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jpeds.2015.09.045","volume":"168","author":"C Ferrara","year":"2016","unstructured":"Ferrara C, Patel P, Becker S, Stanley CA, Kelly A. Biomarkers of insulin for the diagnosis of hyperinsulinemic hypoglycemia in infants and children. J Pediatr. 2016;168:212\u20139. https:\/\/doi.org\/10.1016\/j.jpeds.2015.09.045.","journal-title":"J Pediatr"},{"key":"2693_CR77","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/oby.23444","volume":"30","author":"P Karra","year":"2022","unstructured":"Karra P, Winn M, Pauleck S, Bulsiewicz-Jacobsen A, Peterson L, Coletta A, et al. Metabolic dysfunction and obesity-related cancer: beyond obesity and metabolic syndrome. Obesity (Silver Spring). 2022;30:1323\u201334. https:\/\/doi.org\/10.1002\/oby.23444.","journal-title":"Obesity (Silver Spring)"},{"key":"2693_CR78","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12079-019-00512-y","volume":"13","author":"W Solarek","year":"2019","unstructured":"Solarek W, Koper M, Lewicki S, Szczylik C, Czarnecka AM. Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators. J Cell Commun Signal. 2019;13:381\u201394. https:\/\/doi.org\/10.1007\/s12079-019-00512-y.","journal-title":"J Cell Commun Signal"},{"key":"2693_CR79","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ijc.11544","volume":"108","author":"A Lukanova","year":"2004","unstructured":"Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer. 2004;108:262\u20138. https:\/\/doi.org\/10.1002\/ijc.11544.","journal-title":"Int J Cancer"},{"key":"2693_CR80","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1463-1326.2012.01614.x","volume":"14","author":"V Formica","year":"2012","unstructured":"Formica V, Tesauro M, Cardillo C, Roselli M. Insulinemia and the risk of breast cancer and its relapse. Diabetes Obes Metab. 2012;14:1073\u201380. https:\/\/doi.org\/10.1111\/j.1463-1326.2012.01614.x.","journal-title":"Diabetes Obes Metab"},{"key":"2693_CR81","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.7314\/apjcp.2014.15.2.1031","volume":"15","author":"DR Pandeya","year":"2014","unstructured":"Pandeya DR, Mittal A, Sathian B, Bhatta B. Role of hyperinsulinemia in increased risk of prostate cancer: a case control study from Kathmandu Valley. Asian Pac J Cancer Prev. 2014;15:1031\u20133. https:\/\/doi.org\/10.7314\/apjcp.2014.15.2.1031.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2693_CR82","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jgo.2013.11.004","volume":"5","author":"JJ Liu","year":"2014","unstructured":"Liu JJ, Druta M, Shibata D, Coppola D, Boler I, Elahi A, et al. Metabolic syndrome and colorectal cancer: Is hyperinsulinemia\/insulin receptor-mediated angiogenesis a critical process? J Geriatr Oncol. 2014;5:40\u20138. https:\/\/doi.org\/10.1016\/j.jgo.2013.11.004.","journal-title":"J Geriatr Oncol"},{"key":"2693_CR83","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1158\/0008-5472.CAN-14-2317","volume":"75","author":"MJ Gunter","year":"2015","unstructured":"Gunter MJ, Xie X, Xue X, Kabat GC, Rohan TE, Wassertheil-Smoller S, et al. Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Res. 2015;75:270\u20134. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-2317.","journal-title":"Cancer Res"},{"key":"2693_CR84","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ijc.30729","volume":"141","author":"T Tsujimoto","year":"2017","unstructured":"Tsujimoto T, Kajio H, Sugiyama T. Association between hyperinsulinemia and increased risk of cancer death in nonobese and obese people: A population-based observational study. Int J Cancer. 2017;141:102\u201311. https:\/\/doi.org\/10.1002\/ijc.30729.","journal-title":"Int J Cancer"},{"key":"2693_CR85","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jnci\/djy098","volume":"111","author":"V Morales-Oyarvide","year":"2019","unstructured":"Morales-Oyarvide V, Yuan C, Babic A, Zhang S, Niedzwiecki D, Brand-Miller JC, et al. Dietary insulin load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803 (Alliance). J Natl Cancer Inst. 2019;111:170\u20139. https:\/\/doi.org\/10.1093\/jnci\/djy098.","journal-title":"J Natl Cancer Inst"},{"key":"2693_CR86","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.26355\/eurrev_202105_25833","volume":"25","author":"L Wang","year":"2021","unstructured":"Wang L, Zhang H-J, Liu Y-F, Chen G-Y. Impact of insulin use on outcomes of diabetic breast cancer patients: A systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25:3507\u201318. https:\/\/doi.org\/10.26355\/eurrev_202105_25833.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2693_CR87","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12291-020-00891-9","volume":"36","author":"RK Gupta","year":"2021","unstructured":"Gupta RK, Dholariya SJ, Kaushik S, Gupta SK, Tripathi R, Jain SL. Hyperinsulinemia and Hypoadiponectinemia are associated with increased risk for occurrence of ovarian cancer in non-diabetic women of north Indian population. Indian J Clin Biochem. 2021;36:221\u20137. https:\/\/doi.org\/10.1007\/s12291-020-00891-9.","journal-title":"Indian J Clin Biochem"},{"key":"2693_CR88","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.2337\/dc12-0788","volume":"35","author":"S Suissa","year":"2012","unstructured":"Suissa S, Azoulay L. Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care. 2012;35:2665\u201373. https:\/\/doi.org\/10.2337\/dc12-0788.","journal-title":"Diabetes Care"},{"key":"2693_CR89","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1001\/jama.2022.6147","volume":"327","author":"PJ Goodwin","year":"2022","unstructured":"Goodwin PJ, Chen BE, Gelmon KA, Whelan TJ, Ennis M, Lemieux J, et al. Effect of metformin vs placebo on invasive disease-free survival in patients with breast cancer: The MA.32 randomized clinical trial. JAMA. 2022;327:1963\u201373. https:\/\/doi.org\/10.1001\/jama.2022.6147.","journal-title":"JAMA"},{"key":"2693_CR90","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.tem.2010.06.007","volume":"21","author":"EJ Gallagher","year":"2010","unstructured":"Gallagher EJ, LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 2010;21:610\u20138. https:\/\/doi.org\/10.1016\/j.tem.2010.06.007.","journal-title":"Trends Endocrinol Metab"},{"key":"2693_CR91","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/er.2017-00073","volume":"38","author":"A Belfiore","year":"2017","unstructured":"Belfiore A, Malaguarnera R, Vella V, Lawrence MC, Sciacca L, Frasca F, et al. Insulin receptor isoforms in physiology and disease: an updated view. Endocr Rev. 2017;38:379\u2013431. https:\/\/doi.org\/10.1210\/er.2017-00073.","journal-title":"Endocr Rev"},{"key":"2693_CR92","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13072-019-0290-9","volume":"12","author":"P Senapati","year":"2019","unstructured":"Senapati P, Kato H, Lee M, Leung A, Thai C, Sanchez A, et al. Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer. Epigenetics Chromatin. 2019;12:44. https:\/\/doi.org\/10.1186\/s13072-019-0290-9.","journal-title":"Epigenetics Chromatin"},{"key":"2693_CR93","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mrfmmm.2013.03.006","volume":"745\u2013746","author":"EM Othman","year":"2013","unstructured":"Othman EM, Leyh A, Stopper H. Insulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro. Mutat Res. 2013;745\u2013746:34\u20139. https:\/\/doi.org\/10.1016\/j.mrfmmm.2013.03.006.","journal-title":"Mutat Res"},{"key":"2693_CR94","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","volume":"560","author":"BD Hopkins","year":"2018","unstructured":"Hopkins BD, Pauli C, Du X, Wang DG, Li X, Wu D, et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018;560:499\u2013503. https:\/\/doi.org\/10.1038\/s41586-018-0343-4.","journal-title":"Nature"},{"key":"2693_CR95","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3215","volume":"12","author":"M Pollak","year":"2012","unstructured":"Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer. 2012;12:159\u201369. https:\/\/doi.org\/10.1038\/nrc3215.","journal-title":"Nat Rev Cancer"},{"key":"2693_CR96","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/biomedicines13071571","volume":"13","author":"F Lee","year":"2025","unstructured":"Lee F, Moore J, Markouli M, Ghusn W. The oncogenic burden of obesity: mechanistic links between adiposity and gastrointestinal cancers-a comprehensive narrative review. Biomedicines. 2025;13:1571. https:\/\/doi.org\/10.3390\/biomedicines13071571.","journal-title":"Biomedicines"},{"key":"2693_CR97","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/cancers17071075","volume":"17","author":"C Monge","year":"2025","unstructured":"Monge C, Waldrup B, Carranza FG, Velazquez-Villarreal E. Molecular alterations in TP53, WNT, PI3K, TGF-Beta, and RTK\/RAS pathways in gastric cancer among ethnically heterogeneous cohorts. Cancers (Basel). 2025;17:1075. https:\/\/doi.org\/10.3390\/cancers17071075.","journal-title":"Cancers (Basel)"},{"key":"2693_CR98","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139. https:\/\/doi.org\/10.1038\/nature13480.","journal-title":"Nature"},{"key":"2693_CR99","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3390\/cancers12071724","volume":"12","author":"B Kim","year":"2020","unstructured":"Kim B, Kang SY, Kim D, Heo YJ, Kim K-M. PTEN protein loss and loss-of-function mutations in gastric cancers: the relationship with microsatellite instability, EBV, HER2, and PD-L1 expression. Cancers (Basel). 2020;12:1724. https:\/\/doi.org\/10.3390\/cancers12071724.","journal-title":"Cancers (Basel)"},{"key":"2693_CR100","first-page":"995","volume":"13","author":"E-J Jung","year":"2020","unstructured":"Jung E-J, Suh JH, Kim WH, Kim HS. Clinical significance of PI3K\/Akt\/mTOR signaling in gastric carcinoma. Int J Clin Exp Pathol. 2020;13:995\u20131007.","journal-title":"Int J Clin Exp Pathol"},{"key":"2693_CR101","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023;20:338\u201349. https:\/\/doi.org\/10.1038\/s41571-023-00747-0.","journal-title":"Nat Rev Clin Oncol"},{"key":"2693_CR102","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/ijms21114012","volume":"21","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21:4012. https:\/\/doi.org\/10.3390\/ijms21114012.","journal-title":"Int J Mol Sci"},{"key":"2693_CR103","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893\u2013907. https:\/\/doi.org\/10.1158\/1055-9965.EPI-10-0437.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2693_CR104","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3748\/wjg.v24.i18.1942","volume":"24","author":"M Chivu-Economescu","year":"2018","unstructured":"Chivu-Economescu M, Matei L, Necula LG, Dragu DL, Bleotu C, Diaconu CC. New therapeutic options opened by the molecular classification of gastric cancer. World J Gastroenterol. 2018;24:1942\u201361. https:\/\/doi.org\/10.3748\/wjg.v24.i18.1942.","journal-title":"World J Gastroenterol"},{"key":"2693_CR105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11\u201320. https:\/\/doi.org\/10.1056\/NEJMoa055531.","journal-title":"N Engl J Med"},{"key":"2693_CR106","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.3390\/ijms22073418","volume":"22","author":"L Seeneevassen","year":"2021","unstructured":"Seeneevassen L, Bess\u00e8de E, M\u00e9graud F, Lehours P, Dubus P, Varon C. Gastric cancer: advances in carcinogenesis research and new therapeutic strategies. Int J Mol Sci. 2021;22:3418. https:\/\/doi.org\/10.3390\/ijms22073418.","journal-title":"Int J Mol Sci"},{"key":"2693_CR107","doi-asserted-by":"publisher","first-page":"e23795","DOI":"10.1097\/MD.0000000000023795","volume":"99","author":"X Jiao","year":"2020","unstructured":"Jiao X, Wang Y, Wang F, Wang X. Recurrence pattern and its predictors for advanced gastric cancer after total gastrectomy. Medicine (Baltimore). 2020;99:e23795. https:\/\/doi.org\/10.1097\/MD.0000000000023795.","journal-title":"Medicine (Baltimore)"},{"key":"2693_CR108","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00592-011-0361-2","volume":"49","author":"G Perseghin","year":"2012","unstructured":"Perseghin G, Calori G, Lattuada G, Ragogna F, Dugnani E, Garancini MP, et al. Insulin resistance\/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up. Acta Diabetol. 2012;49:421\u20138. https:\/\/doi.org\/10.1007\/s00592-011-0361-2.","journal-title":"Acta Diabetol"},{"key":"2693_CR109","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/ijc.29098","volume":"136","author":"A Hidaka","year":"2015","unstructured":"Hidaka A, Sasazuki S, Goto A, Sawada N, Shimazu T, Yamaji T, et al. Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Int J Cancer. 2015;136:1402\u201310. https:\/\/doi.org\/10.1002\/ijc.29098.","journal-title":"Int J Cancer"},{"key":"2693_CR110","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s10120-019-00964-6","volume":"22","author":"SM Heckl","year":"2019","unstructured":"Heckl SM, Wiesener V, Behrens H-M, Ulase D, Kr\u00fcger S, R\u00f6cken C. The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications. Gastric Cancer. 2019;22:1130\u201342. https:\/\/doi.org\/10.1007\/s10120-019-00964-6.","journal-title":"Gastric Cancer"},{"key":"2693_CR111","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5009\/gnl17556","volume":"13","author":"HJ Kwon","year":"2019","unstructured":"Kwon HJ, Park MI, Park SJ, Moon W, Kim SE, Kim JH, et al. Insulin resistance is associated with early gastric cancer: a prospective multicenter case control study. Gut Liver. 2019;13:154\u201360. https:\/\/doi.org\/10.5009\/gnl17556.","journal-title":"Gut Liver"},{"key":"2693_CR112","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1080\/01635581.2021.2014906","volume":"74","author":"F Amiry","year":"2022","unstructured":"Amiry F, Barekzai AM, Aminianfar A, Esmaillzadeh A. The association between dietary insulin index and load with gastric cancer in Afghanistan. Nutr Cancer. 2022;74:2489\u201398. https:\/\/doi.org\/10.1080\/01635581.2021.2014906. Routledge.","journal-title":"Nutr Cancer"},{"key":"2693_CR113","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10120-021-01236-y","volume":"25","author":"M Saisana","year":"2022","unstructured":"Saisana M, Griffin SM, May FEB. Insulin and the insulin receptor collaborate to promote human gastric cancer. Gastric Cancer. 2022;25:107\u201323. https:\/\/doi.org\/10.1007\/s10120-021-01236-y.","journal-title":"Gastric Cancer"},{"key":"2693_CR114","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3892\/ol.2014.2687","volume":"9","author":"H Li","year":"2015","unstructured":"Li H, Xu L, Zhao L, Ma Y, Zhu Z, Liu Y, et al. Insulin-like growth factor-I induces epithelial to mesenchymal transition via GSK-3\u03b2 and ZEB2 in the BGC-823 gastric cancer cell line. Oncol Lett. 2015;9:143\u20138. https:\/\/doi.org\/10.3892\/ol.2014.2687.","journal-title":"Oncol Lett"},{"key":"2693_CR115","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1002\/cncr.25893","volume":"117","author":"H Li","year":"2011","unstructured":"Li H, Adachi Y, Yamamoto H, Min Y, Ohashi H, Ii M, et al. Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45. Cancer. 2011;117:3135\u201347. https:\/\/doi.org\/10.1002\/cncr.25893.","journal-title":"Cancer"},{"key":"2693_CR116","doi-asserted-by":"publisher","first-page":"54445","DOI":"10.18632\/oncotarget.10642","volume":"7","author":"M Saisana","year":"2016","unstructured":"Saisana M, Griffin SM, May FEB. Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET -unamplified gastric cancer with and without Ras pathway activation. Oncotarget. 2016;7:54445\u201362. https:\/\/doi.org\/10.18632\/oncotarget.10642.","journal-title":"Oncotarget"},{"key":"2693_CR117","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s13277-015-3909-x","volume":"37","author":"C Li","year":"2016","unstructured":"Li C, Li J, Wu D, Han G. The involvement of survivin in insulin-like growth factor 1-induced epithelial-mesenchymal transition in gastric cancer. Tumour Biol. 2016;37:1091\u20136. https:\/\/doi.org\/10.1007\/s13277-015-3909-x.","journal-title":"Tumour Biol"},{"key":"2693_CR118","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13046-015-0151-8","volume":"34","author":"Z Wei","year":"2015","unstructured":"Wei Z, Liang L, Junsong L, Rui C, Shuai C, Guanglin Q, et al. The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28. J Exp Clin Cancer Res. 2015;34:64. https:\/\/doi.org\/10.1186\/s13046-015-0151-8.","journal-title":"J Exp Clin Cancer Res"},{"key":"2693_CR119","doi-asserted-by":"publisher","first-page":"836389","DOI":"10.3389\/fonc.2022.836389","volume":"12","author":"M Ma","year":"2022","unstructured":"Ma M, Sun J, Liu Z, Ouyang S, Zhang Z, Zeng Z, et al. The immune microenvironment in gastric cancer: prognostic prediction. Front Oncol. 2022;12:836389. https:\/\/doi.org\/10.3389\/fonc.2022.836389.","journal-title":"Front Oncol"},{"key":"2693_CR120","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1158\/2326-6066.CIR-18-0436","volume":"7","author":"D Zeng","year":"2019","unstructured":"Zeng D, Li M, Zhou R, Zhang J, Sun H, Shi M, et al. Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures. Cancer Immunol Res. 2019;7:737\u201350. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0436.","journal-title":"Cancer Immunol Res"},{"key":"2693_CR121","doi-asserted-by":"publisher","first-page":"167123","DOI":"10.1016\/j.bbadis.2024.167123","volume":"1870","author":"X Jia","year":"2024","unstructured":"Jia X, Li Z, Zhou R, Feng W, Yi L, Zhang H, et al. Single cell and bulk RNA sequencing identifies tumor microenvironment subtypes and chemoresistance-related IGF1+ cancer-associated fibroblast in gastric cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024;1870:167123. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167123.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"2693_CR122","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.7150\/jca.50370","volume":"12","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Zhao R, Song C, Wang H, Rong J, Wang F, et al. Increased IGFBP7 expression correlates with poor prognosis and immune infiltration in gastric cancer. J Cancer. 2021;12:1343\u201355. https:\/\/doi.org\/10.7150\/jca.50370.","journal-title":"J Cancer"},{"key":"2693_CR123","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s10495-024-02020-w","volume":"29","author":"K Lin","year":"2024","unstructured":"Lin K, Lin X, Luo F. IGF2BP3 boosts lactate generation to accelerate gastric cancer immune evasion. Apoptosis. 2024;29:2147\u201360. https:\/\/doi.org\/10.1007\/s10495-024-02020-w.","journal-title":"Apoptosis"},{"key":"2693_CR124","doi-asserted-by":"publisher","first-page":"111462","DOI":"10.1016\/j.cellsig.2024.111462","volume":"124","author":"Z Li","year":"2024","unstructured":"Li Z, Liang P, Chen Z, Chen Z, Jin T, He F, et al. CAF-secreted LOX promotes PD-L1 expression via histone Lactylation and regulates tumor EMT through TGF\u03b2\/IGF1 signaling in gastric Cancer. Cell Signal. 2024;124:111462. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111462.","journal-title":"Cell Signal"},{"key":"2693_CR125","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.3390\/cancers14194961","volume":"14","author":"S Russi","year":"2022","unstructured":"Russi S, Marano L, Laurino S, Calice G, Scala D, Marino G, et al. Gene regulatory network characterization of gastric cancer\u2019s histological subtypes: distinctive biological and clinically relevant master regulators. Cancers (Basel). 2022;14:4961. https:\/\/doi.org\/10.3390\/cancers14194961.","journal-title":"Cancers (Basel)"},{"key":"2693_CR126","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"2693_CR127","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004.","journal-title":"Cell Syst"},{"key":"2693_CR128","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","volume":"7","author":"Z-N Lei","year":"2022","unstructured":"Lei Z-N, Teng Q-X, Tian Q, Chen W, Xie Y, Wu K, et al. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct Target Ther. 2022;7:358. https:\/\/doi.org\/10.1038\/s41392-022-01190-w.","journal-title":"Signal Transduct Target Ther"},{"key":"2693_CR129","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim K-M, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21:449\u201356. https:\/\/doi.org\/10.1038\/nm.3850.","journal-title":"Nat Med"},{"key":"2693_CR130","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41467-018-04179-8","volume":"9","author":"SC Oh","year":"2018","unstructured":"Oh SC, Sohn BH, Cheong J-H, Kim S-B, Lee JE, Park KC, et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 2018;9:1777. https:\/\/doi.org\/10.1038\/s41467-018-04179-8.","journal-title":"Nat Commun"},{"key":"2693_CR131","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cimb43020042","volume":"43","author":"WH Talib","year":"2021","unstructured":"Talib WH, Mahmod AI, Kamal A, Rashid HM, Alashqar AMD, Khater S, et al. Ketogenic diet in cancer prevention and therapy: molecular targets and therapeutic opportunities. Curr Issues Mol Biol. 2021;43:558\u201389. https:\/\/doi.org\/10.3390\/cimb43020042.","journal-title":"Curr Issues Mol Biol"},{"key":"2693_CR132","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1194\/jlr.M082040","volume":"59","author":"J Zhang","year":"2018","unstructured":"Zhang J, Jia P-P, Liu Q-L, Cong M-H, Gao Y, Shi H-P, et al. Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo. J Lipid Res. 2018;59:625\u201334. https:\/\/doi.org\/10.1194\/jlr.M082040.","journal-title":"J Lipid Res"},{"key":"2693_CR133","doi-asserted-by":"publisher","first-page":"8545","DOI":"10.2147\/CMAR.S264032","volume":"12","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wen L, Zhou Q, He K, Teng L. Preventative and therapeutic effects of metformin in gastric cancer: a new contribution of an old friend. Cancer Manag Res. 2020;12:8545. https:\/\/doi.org\/10.2147\/CMAR.S264032.","journal-title":"Cancer Manag Res"},{"key":"2693_CR134","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-2407-8-122","volume":"8","author":"C Otto","year":"2008","unstructured":"Otto C, Kaemmerer U, Illert B, Muehling B, Pfetzer N, Wittig R, et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer. 2008;8:122. https:\/\/doi.org\/10.1186\/1471-2407-8-122.","journal-title":"BMC Cancer"},{"key":"2693_CR135","doi-asserted-by":"publisher","first-page":"e14407","DOI":"10.1111\/jfbc.14407","volume":"46","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Deng B, Akbari A, Liu Q, Zhu B. The ketogenic diet could improve the efficacy of curcumin and Oldenlandia diffusa extract in the treatment of gastric cancer by increasing miR340 expression and apoptosis mediated by autophagy, oxidative stress, and angiogenesis. J Food Biochem. 2022;46:e14407. https:\/\/doi.org\/10.1111\/jfbc.14407.","journal-title":"J Food Biochem"},{"key":"2693_CR136","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.numecd.2015.05.005","volume":"25","author":"LSA Augustin","year":"2015","unstructured":"Augustin LSA, Kendall CWC, Jenkins DJA, Willett WC, Astrup A, Barclay AW, et al. Glycemic index, glycemic load and glycemic response: an International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC). Nutr Metab Cardiovasc Dis. 2015;25:795\u2013815. https:\/\/doi.org\/10.1016\/j.numecd.2015.05.005.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2693_CR137","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/sj.bjc.6604894","volume":"100","author":"P Bertuccio","year":"2009","unstructured":"Bertuccio P, Praud D, Chatenoud L, Lucenteforte E, Bosetti C, Pelucchi C, et al. Dietary glycemic load and gastric cancer risk in Italy. Br J Cancer. 2009;100:558\u201361. https:\/\/doi.org\/10.1038\/sj.bjc.6604894.","journal-title":"Br J Cancer"},{"key":"2693_CR138","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/annonc\/mdh130","volume":"15","author":"LSA Augustin","year":"2004","unstructured":"Augustin LSA, Gallus S, Negri E, La Vecchia C. Glycemic index, glycemic load and risk of gastric cancer. Ann Oncol. 2004;15:581\u20134. https:\/\/doi.org\/10.1093\/annonc\/mdh130.","journal-title":"Ann Oncol"},{"key":"2693_CR139","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1158\/1535-7163.MCT-11-0594","volume":"11","author":"K Kato","year":"2012","unstructured":"Kato K, Gong J, Iwama H, Kitanaka A, Tani J, Miyoshi H, et al. The antidiabetic drug Metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Mol Cancer Ther. 2012;11:549\u201360. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0594.","journal-title":"Mol Cancer Ther"},{"key":"2693_CR140","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4161\/15384047.2014.987021","volume":"16","author":"G Han","year":"2015","unstructured":"Han G, Gong H, Wang Y, Guo S, Liu K. AMPK\/mTOR-mediated inhibition of survivin partly contributes to Metformin-induced apoptosis in human gastric cancer cell. Cancer Biol Ther. 2015;16:77\u201387. https:\/\/doi.org\/10.4161\/15384047.2014.987021.","journal-title":"Cancer Biol Ther"},{"key":"2693_CR141","doi-asserted-by":"publisher","first-page":"321","DOI":"10.18388\/abp.2020_5750","volume":"69","author":"M Zhu","year":"2022","unstructured":"Zhu M, Wang J, Zhou R. Combination of metformin and oxaliplatin inhibits gastric cancer cell proliferation and induces apoptosis. Acta Biochim Pol. 2022;69:321\u20136. https:\/\/doi.org\/10.18388\/abp.2020_5750.","journal-title":"Acta Biochim Pol"},{"key":"2693_CR142","doi-asserted-by":"publisher","first-page":"12748","DOI":"10.18632\/oncotarget.3327","volume":"6","author":"Y Yu","year":"2015","unstructured":"Yu Y, Fang W, Xia T, Chen Y, Gao Y, Jiao X, et al. Metformin potentiates rapamycin and cisplatin in gastric cancer in mice. Oncotarget. 2015;6:12748. https:\/\/doi.org\/10.18632\/oncotarget.3327.","journal-title":"Oncotarget"},{"key":"2693_CR143","doi-asserted-by":"publisher","first-page":"116367","DOI":"10.1016\/j.bcp.2024.116367","volume":"226","author":"K Wang","year":"2024","unstructured":"Wang K, Chen Y, Zhang M, Wang S, Yao S, Gong Z, et al. Metformin suppresses gastric cancer progression by disrupting the STAT1-PRMT1 axis. Biochem Pharmacol. 2024;226:116367. https:\/\/doi.org\/10.1016\/j.bcp.2024.116367.","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"2693_CR144","doi-asserted-by":"publisher","first-page":"10155","DOI":"10.1007\/s00210-025-03879-5","volume":"398","author":"V Asghariazar","year":"2025","unstructured":"Asghariazar V, Ojarood MV, Vatankhah MA, Panahizadeh R, Haris HM, Najafzadeh N, et al. Metformin reverses 5-FU chemoresistance by downregulating DKK1, WNT5A, and ABCB1 expressions in gastric cancer: an experimental and bioinformatic study. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(8):10155\u201367. https:\/\/doi.org\/10.1007\/s00210-025-03879-5.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2693_CR145","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.pharep.2015.05.005","volume":"67","author":"A Tokajuk","year":"2015","unstructured":"Tokajuk A, Krzy\u017canowska-Grycel E, Tokajuk A, Grycel S, Sadowska A, Car H. Antidiabetic drugs and risk of cancer. Pharmacol Rep. 2015;67:1240\u201350. https:\/\/doi.org\/10.1016\/j.pharep.2015.05.005.","journal-title":"Pharmacol Rep"},{"key":"2693_CR146","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.3892\/or.2013.2704","volume":"30","author":"F-Z Chen","year":"2013","unstructured":"Chen F-Z, Mo X-M, Wang Q-P, Li J, Zhang L. Effects of Rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice. Oncol Rep. 2013;30:2705\u201312. https:\/\/doi.org\/10.3892\/or.2013.2704.","journal-title":"Oncol Rep"},{"key":"2693_CR147","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/mmr.2010.381","volume":"4","author":"C Wang","year":"2011","unstructured":"Wang C, Wang J, Bai P. Troglitazone induces apoptosis in gastric cancer cells through the NAG-1 pathway. Mol Med Rep. 2011;4:93\u20137. https:\/\/doi.org\/10.3892\/mmr.2010.381.","journal-title":"Mol Med Rep"},{"key":"2693_CR148","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/jcpt.12151","volume":"39","author":"HC Lin","year":"2014","unstructured":"Lin HC, Hsu YT, Kachingwe BH, Hsu CY, Uang YS, Wang LH. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study. J Clin Pharm Ther. 2014;39:354\u201360. https:\/\/doi.org\/10.1111\/jcpt.12151.","journal-title":"J Clin Pharm Ther"},{"key":"2693_CR149","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/1471-2407-13-420","volume":"13","author":"S-S Chang","year":"2013","unstructured":"Chang S-S, Hu H-Y. Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case-control study. BMC Cancer. 2013;13:420. https:\/\/doi.org\/10.1186\/1471-2407-13-420.","journal-title":"BMC Cancer"},{"key":"2693_CR150","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1186\/s40001-025-03438-x","volume":"30","author":"Y Shu","year":"2025","unstructured":"Shu Y, Chen X, Wang P. Effects of canagliflozin combined with metformin therapy on insulin sensitivity in patients with type 2 diabetes mellitus. Eur J Med Res. 2025;30:1157. https:\/\/doi.org\/10.1186\/s40001-025-03438-x.","journal-title":"Eur J Med Res"},{"key":"2693_CR151","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12902-022-00949-0","volume":"22","author":"Z Hao","year":"2022","unstructured":"Hao Z, Sun Y, Li G, Shen Y, Wen Y, Liu Y. Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes. BMC Endocr Disord. 2022;22:37. https:\/\/doi.org\/10.1186\/s12902-022-00949-0.","journal-title":"BMC Endocr Disord"},{"key":"2693_CR152","doi-asserted-by":"publisher","first-page":"1057455","DOI":"10.3389\/fonc.2022.1057455","volume":"12","author":"D Jiang","year":"2022","unstructured":"Jiang D, Ma P. Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis. Front Oncol. 2022;12:1057455. https:\/\/doi.org\/10.3389\/fonc.2022.1057455.","journal-title":"Front Oncol"},{"key":"2693_CR153","unstructured":"Zandberg D. A Phase II Clinical Trial of Anti-PD-1 mAb Therapy Alone or With Metabolic Modulators to Reverse Tumor Hypoxia and Immune Dysfunction in Solid Tumor Malignancies [Internet]. clinicaltrials.gov; 2025 Feb. Report No.: NCT04114136. https:\/\/clinicaltrials.gov\/study\/NCT04114136. Accessed 23 Mar 2026."},{"key":"2693_CR154","unstructured":"Fuxiang Z. Clinical Research of High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors [Internet]. clinicaltrials.gov; 2023 Sept. Report No.: NCT04033107. https:\/\/clinicaltrials.gov\/study\/NCT04033107. Accessed 23 Mar 2026."},{"key":"2693_CR155","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13045-023-01510-9","volume":"16","author":"S Pusceddu","year":"2023","unstructured":"Pusceddu S, Corti F, Prinzi N, Nichetti F, Ljevar S, Busico A, et al. Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2. J Hematol Oncol. 2023;16:119. https:\/\/doi.org\/10.1186\/s13045-023-01510-9.","journal-title":"J Hematol Oncol"},{"key":"2693_CR156","doi-asserted-by":"publisher","first-page":"e38800","DOI":"10.1016\/j.heliyon.2024.e38800","volume":"10","author":"J Nie","year":"2024","unstructured":"Nie J, Zhang H, Li X, Qin J, Zhou J, Lu Y, et al. Pachymic acid promotes ferroptosis and inhibits gastric cancer progression by suppressing the PDGFRB-mediated PI3K\/Akt pathway. Heliyon. 2024;10:e38800. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38800.","journal-title":"Heliyon"},{"key":"2693_CR157","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.7150\/jca.31303","volume":"10","author":"W Si","year":"2019","unstructured":"Si W, Lyu J, Liu Z, Wang C, Huang J, Jiang L, et al. Cucurbitacin E inhibits cellular proliferation and enhances the chemo-response in gastric cancer by suppressing AKt activation. J Cancer. 2019;10:5843\u201351. https:\/\/doi.org\/10.7150\/jca.31303.","journal-title":"J Cancer"},{"key":"2693_CR158","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3892\/or.2018.6361","volume":"39","author":"YZ Zhang","year":"2018","unstructured":"Zhang YZ, Wang CF, Zhang LF. Cucurbitacin D impedes gastric cancer cell survival via activation of the iNOS\/NO and inhibition of the Akt signalling pathway. Oncol Rep. 2018;39:2595\u2013603. https:\/\/doi.org\/10.3892\/or.2018.6361.","journal-title":"Oncol Rep"},{"key":"2693_CR159","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/or.2017.5648","volume":"38","author":"X Liu","year":"2017","unstructured":"Liu X, Duan C, Ji J, Zhang T, Yuan X, Zhang Y, et al. Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A\/PP2A\/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells. Oncol Rep. 2017;38:271\u20138. https:\/\/doi.org\/10.3892\/or.2017.5648.","journal-title":"Oncol Rep"},{"key":"2693_CR160","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/biomedicines10061350","volume":"10","author":"C-H Lee","year":"2022","unstructured":"Lee C-H, Tsai H-Y, Chen C-L, Chen J-L, Lu C-C, Fang Y-P, et al. Isoliquiritigenin inhibits gastric cancer stemness, modulates tumor microenvironment, and suppresses tumor growth through Glucose-Regulated Protein 78 downregulation. Biomedicines. 2022;10:1350. https:\/\/doi.org\/10.3390\/biomedicines10061350.","journal-title":"Biomedicines"},{"issue":"1","key":"2693_CR161","doi-asserted-by":"publisher","first-page":"rgaf087","DOI":"10.1093\/jpp\/rgaf087","volume":"78","author":"S Chen","year":"2025","unstructured":"Chen S, Wang H, Lei M, Li Y, Wang Q, Wang H, et al. Gallic acid potentiates the tumour-killing function of CD8+ T cells in gastric cancer. J Pharm Pharmacol. 2025;78(1):rgaf087. https:\/\/doi.org\/10.1093\/jpp\/rgaf087.","journal-title":"J Pharm Pharmacol"},{"key":"2693_CR162","doi-asserted-by":"publisher","first-page":"118051","DOI":"10.1016\/j.lfs.2020.118051","volume":"257","author":"M Najafi","year":"2020","unstructured":"Najafi M, Mortezaee K, Rahimifard M, Farhood B, Haghi-Aminjan H. The role of curcumin\/curcuminoids during gastric cancer chemotherapy: a systematic review of non-clinical study. Life Sci. 2020;257:118051. https:\/\/doi.org\/10.1016\/j.lfs.2020.118051.","journal-title":"Life Sci"},{"key":"2693_CR163","doi-asserted-by":"publisher","first-page":"120266","DOI":"10.1016\/j.lfs.2021.120266","volume":"290","author":"M Xu","year":"2022","unstructured":"Xu M, Ren L, Fan J, Huang L, Zhou L, Li X, et al. Berberine inhibits gastric cancer development and progression by regulating the JAK2\/STAT3 pathway and downregulating IL-6. Life Sci. 2022;290:120266. https:\/\/doi.org\/10.1016\/j.lfs.2021.120266.","journal-title":"Life Sci"},{"key":"2693_CR164","doi-asserted-by":"publisher","first-page":"110245","DOI":"10.1016\/j.biopha.2020.110245","volume":"128","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Wang X, Cao S, Sun Y, He X, Jiang B, et al. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK\/mTOR\/p70S6K and Akt signaling pathways. Biomed Pharmacother. 2020;128:110245. https:\/\/doi.org\/10.1016\/j.biopha.2020.110245.","journal-title":"Biomed Pharmacother"},{"key":"2693_CR165","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3390\/md12063466","volume":"12","author":"K Toume","year":"2014","unstructured":"Toume K, Tsukahara K, Ito H, Arai MA, Ishibashi M. Chromomycins A2 and A3 from marine actinomycetes with TRAIL resistance-overcoming and Wnt signal inhibitory activities. Mar Drugs. 2014;12:3466\u201376. https:\/\/doi.org\/10.3390\/md12063466.","journal-title":"Mar Drugs"},{"key":"2693_CR166","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/plants10061047","volume":"10","author":"W-J Kim","year":"2021","unstructured":"Kim W-J, Kim W, Bae J-M, Gim J, Kim S-J. Dehydroabietic Acid is a novel Survivin inhibitor for gastric cancer. Plants (Basel). 2021;10:1047. https:\/\/doi.org\/10.3390\/plants10061047.","journal-title":"Plants (Basel)"},{"key":"2693_CR167","doi-asserted-by":"publisher","first-page":"30803","DOI":"10.1038\/s41598-024-81196-2","volume":"14","author":"Y Song","year":"2024","unstructured":"Song Y, Zhao H, Yu R, Zhang Y, Zou Y, Liu X, et al. Wogonin suppresses proliferation, invasion and migration in gastric cancer cells via targeting the JAK-STAT3 pathway. Sci Rep. 2024;14:30803. https:\/\/doi.org\/10.1038\/s41598-024-81196-2.","journal-title":"Sci Rep"},{"key":"2693_CR168","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41580-025-00826-3","volume":"26","author":"E Choi","year":"2025","unstructured":"Choi E, Duan C, Bai X. Regulation and function of insulin-IGF receptor signaling. Nat Rev Mol Cell Biol. 2025;26:558\u201380. https:\/\/doi.org\/10.1038\/s41580-025-00826-3.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2693_CR169","unstructured":"National Cancer Institute (NCI). Randomized, Double-Blind, Placebo-Controlled Trial of Meriva\u00ae (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric Carcinogenesis [Internet]. clinicaltrials.gov; 2025 Sept. Report No.: NCT02782949. https:\/\/clinicaltrials.gov\/study\/NCT02782949. Accessed 23 Mar 2026."},{"key":"2693_CR170","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/apt.12660","volume":"39","author":"Y-I Kim","year":"2014","unstructured":"Kim Y-I, Kim SY, Cho S-J, Park J-H, Choi IJ, Lee YJ, et al. Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study. Aliment Pharmacol Ther. 2014;39:854\u201363. https:\/\/doi.org\/10.1111\/apt.12660.","journal-title":"Aliment Pharmacol Ther"},{"key":"2693_CR171","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.18632\/aging.101019","volume":"8","author":"C-H Tseng","year":"2016","unstructured":"Tseng C-H. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus. Aging (Albany NY). 2016;8:1636. https:\/\/doi.org\/10.18632\/aging.101019.","journal-title":"Aging (Albany NY)"},{"key":"2693_CR172","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/jnci\/djy144","volume":"111","author":"KS Cheung","year":"2019","unstructured":"Cheung KS, Chan EW, Wong AYS, Chen L, Seto WK, Wong ICK, et al. Metformin use and gastric cancer risk in diabetic patients after helicobacter pylori eradication. J Natl Cancer Inst. 2019;111:484\u20139. https:\/\/doi.org\/10.1093\/jnci\/djy144.","journal-title":"J Natl Cancer Inst"},{"key":"2693_CR173","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/cam4.4514","volume":"11","author":"SI Seo","year":"2022","unstructured":"Seo SI, Park CH, Kim TJ, Bang CS, Kim JY, Lee KJ, et al. Aspirin, metformin, and statin use on the risk of gastric cancer: a nationwide population-based cohort study in Korea with systematic review and meta-analysis. Cancer Med. 2022;11:1217\u201331. https:\/\/doi.org\/10.1002\/cam4.4514.","journal-title":"Cancer Med"},{"key":"2693_CR174","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3390\/cancers12082013","volume":"12","author":"W-S Chung","year":"2020","unstructured":"Chung W-S, Le P-H, Kuo C-J, Chen T-H, Kuo C-F, Chiou M-J, et al. Impact of metformin use on survival in patients with gastric cancer and diabetes mellitus following gastrectomy. Cancers. 2020;12:2013. https:\/\/doi.org\/10.3390\/cancers12082013.","journal-title":"Cancers"},{"key":"2693_CR175","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/SLA.0000000000001086","volume":"263","author":"C Lee","year":"2016","unstructured":"Lee C, Jung M, Jung I, Heo SJ, Jeong YH, An JY, et al. Cumulative metformin use and its impact on survival in gastric cancer patients after gastrectomy. Ann Surg. 2016;263:96\u2013102. https:\/\/doi.org\/10.1097\/SLA.0000000000001086.","journal-title":"Ann Surg"},{"key":"2693_CR176","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.canep.2018.02.001","volume":"53","author":"O Lacroix","year":"2018","unstructured":"Lacroix O, Couttenier A, Vaes E, Cardwell CR, De Schutter H, Robert A. Impact of metformin on gastric adenocarcinoma survival: a Belgian population based study. Cancer Epidemiol. 2018;53:149\u201355. https:\/\/doi.org\/10.1016\/j.canep.2018.02.001.","journal-title":"Cancer Epidemiol"},{"key":"2693_CR177","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/COC.0000000000000627","volume":"42","author":"HS Seo","year":"2019","unstructured":"Seo HS, Jung YJ, Kim JH, Lee HH, Park CH. The effect of metformin on prognosis in patients with locally advanced gastric cancer associated with type 2 diabetes mellitus. Am J Clin Oncol. 2019;42:909\u201317. https:\/\/doi.org\/10.1097\/COC.0000000000000627.","journal-title":"Am J Clin Oncol"},{"key":"2693_CR178","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4143\/crt.2017.591","volume":"51","author":"ML Baglia","year":"2019","unstructured":"Baglia ML, Cui Y, Zheng T, Yang G, Li H, You M, et al. Diabetes medication use in association with survival among patients of breast, colorectal, lung, or gastric cancer. Cancer Res Treat. 2019;51:538\u201346. https:\/\/doi.org\/10.4143\/crt.2017.591.","journal-title":"Cancer Res Treat"},{"key":"2693_CR179","doi-asserted-by":"publisher","first-page":"631","DOI":"10.21147\/j.issn.1000-9604.2020.05.08","volume":"32","author":"X Chen","year":"2020","unstructured":"Chen X, Chen Y, Li T, Jun L, Lin T, Hu Y, et al. Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy. Chin J Cancer Res. 2020;32:631\u201344. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2020.05.08.","journal-title":"Chin J Cancer Res"},{"key":"2693_CR180","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.18632\/aging.102245","volume":"11","author":"A Dulskas","year":"2019","unstructured":"Dulskas A, Patasius A, Linkeviciute-Ulinskiene D, Zabuliene L, Smailyte G. A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer. Aging (Albany NY). 2019;11:7197\u2013205. https:\/\/doi.org\/10.18632\/aging.102245.","journal-title":"Aging (Albany NY)"},{"key":"2693_CR181","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41416-021-01408-8","volume":"125","author":"J Zheng","year":"2021","unstructured":"Zheng J, Santoni G, Xie S-H, Lagergren J. Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study. Br J Cancer. 2021;125:277\u201383. https:\/\/doi.org\/10.1038\/s41416-021-01408-8.","journal-title":"Br J Cancer"},{"key":"2693_CR182","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12876-022-02514-4","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Hu D, Fan Z, Yu J, Zhang S, Lin Y, et al. Prognostic value of long-term antidiabetic and antihypertensive therapy in postoperative gastric cancer patients: the FIESTA study. BMC Gastroenterol. 2022;22:429. https:\/\/doi.org\/10.1186\/s12876-022-02514-4.","journal-title":"BMC Gastroenterol"},{"key":"2693_CR183","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1158\/1940-6207.CAPR-20-0123","volume":"14","author":"MH Cho","year":"2021","unstructured":"Cho MH, Yoo TG, Jeong S-M, Shin DW. Association of aspirin, metformin, and statin use with gastric cancer incidence and mortality: a nationwide cohort study. Cancer Prev Res (Phila). 2021;14:95\u2013104. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-20-0123.","journal-title":"Cancer Prev Res (Phila)"},{"key":"2693_CR184","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.3390\/cancers15164134","volume":"15","author":"J-H Joo","year":"2023","unstructured":"Joo J-H, Zhang H-S, Chun J, Park E-C, Park S. Association of metformin treatment with risk for death in diabetic patients with concomitant gastric cancer. Cancers. 2023;15:4134. https:\/\/doi.org\/10.3390\/cancers15164134.","journal-title":"Cancers"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02693-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02693-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02693-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:49:35Z","timestamp":1784162975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02693-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":184,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2693"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02693-8","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"176"}}